NTRA
Natera Inc

2,268
Loading...
Loading...
News
all
press releases
Signatera Test Selected for NRG-Sponsored Phase III ARCHER Trial in Bladder Cancer
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the activation of the NRG Oncology trial, ARCHER (NRG-GU015), a randomized, phase III study in...
Business Wire·24d ago
News Placeholder
More News
News Placeholder
Natera Shares Rise on the Launch of AI Platform for Precision Oncology
NTRA shares gain after unveiling its in-house AI platform, built on vast oncology datasets to transform precision cancer care.
Zacks·26d ago
News Placeholder
Compared to Estimates, Natera (NTRA) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Natera (NTRA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·1mo ago
News Placeholder
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates
Natera (NTRA) delivered earnings and revenue surprises of -23.33% and +15.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Pediatrix Medical Group (MD) Q2 Earnings and Revenues Top Estimates
Pediatrix Medical Group (MD) delivered earnings and revenue surprises of +26.19% and +0.43%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Medpace (MEDP) Q2 Earnings and Revenues Surpass Estimates
Medpace (MEDP) delivered earnings and revenue surprises of +3.33% and +11.48%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Tempus AI Revenues & Profit Rise: What to Expect Ahead of Q2 Release
TEM's revenue and gross profit are climbing fast as new AI tools and data services boost margins ahead of Q2 earnings.
Zacks·3mo ago
News Placeholder
Should Vanguard Small-Cap Growth ETF (VBK) Be on Your Investing Radar?
Zacks·3mo ago
News Placeholder
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
Zacks·4mo ago
News Placeholder
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Zacks·4mo ago

Latest NTRA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.